0HR2 Stock Chart & Stats
$256.25
$1.21(0.47%)
At close: 4:00 PM EDT
$256.25
$1.21(0.47%)
Day’s Range― - ―
52-Week Range$218.45 - $329.50
Previous CloseN/A
Volume6.00
Average Volume (3M)3.15K
Market Cap
$101.03B
Enterprise Value$81.37K
Total Cash (Recent Filing)$2.28B
Total Debt (Recent Filing)$3.42B
Price to Earnings (P/E)23.7
Beta0.30
Next Earnings
Oct 28, 2026EPS Estimate
2.94Next Dividend Ex-DateN/A
Dividend Yield4.01%
Share Statistics
EPS (TTM)11.85
Shares Outstanding359,576,100
10 Day Avg. Volume2,873
30 Day Avg. Volume3,148
Financial Highlights & Ratios
PEG Ratio1.59
Price to Book (P/B)3.42
Price to Sales (P/S)15.06
P/FCF Ratio23.42
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$277.58Price Target Upside8.33% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)12.27
Revenue Forecast (FY)$7.03B
Bulls Say, Bears Say
Bulls Say
Exceptional Profitability And Cash ConversionCME’s exchange model produces unusually high profitability, while free cash flow nearly matches net income. This combination supports ongoing investment, shareholder distributions and resilience across changing market-volume conditions.
Recurring Market-data GrowthSustained market-data expansion diversifies CME beyond transaction volumes and adds recurring, subscription-like revenue. The long record of growth indicates durable customer reliance on CME pricing and reference data.
Broad Product Innovation And Market ReachCME continues extending its clearing and risk-management infrastructure into new exposures, including equity factors and renewable power. A broader product set can deepen customer relationships and create additional long-term volume and clearing opportunities.
Bears Say
Margin Compression From Prior PeaksLower margins indicate that CME’s exceptional profitability may not be fully immune to cost growth, product mix changes or operating investment. Persistent compression would reduce the earnings benefit from future revenue expansion.
Regulatory Uncertainty May Delay Product ExpansionRegulatory intervention can postpone launches, increase compliance costs and limit CME’s ability to respond quickly to evolving customer demand. Uncertainty is especially relevant as the company expands trading hours and introduces novel contracts.
Persistent Governance ComplexityThe multi-class structure can concentrate influence and reduce the ability of ordinary shareholders to shape board composition. That may constrain governance flexibility and preserve structural oversight concerns over the medium term.
CME Group News
0HR2 FAQ
What was CME Group’s price range in the past 12 months?
CME Group lowest share price was $218.45 and its highest was $329.50 in the past 12 months.
What is CME Group’s market cap?
CME Group’s market cap is $101.03B.
When is CME Group’s upcoming earnings report date?
CME Group’s upcoming earnings report date is Oct 28, 2026 which is in 61 days.
How were CME Group’s earnings last quarter?
CME Group released its earnings results on Jul 22, 2026. The company reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.905 by $0.085.
Is CME Group overvalued?
According to Wall Street analysts CME Group’s price is currently Undervalued.
Does CME Group pay dividends?
CME Group pays a Semiannually dividend of $1.3 which represents an annual dividend yield of 4.01%. See more information on CME Group dividends here
What is CME Group’s EPS estimate?
CME Group’s EPS estimate is 2.94.
How many shares outstanding does CME Group have?
CME Group has 359,576,100 shares outstanding.
What happened to CME Group’s price movement after its last earnings report?
CME Group reported an EPS of $2.99 in its last earnings report, beating expectations of $2.905. Following the earnings report the stock price went up 4.677%.
Which hedge fund is a major shareholder of CME Group?
Currently, no hedge funds are holding shares in GB:0HR2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CME Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$277.58 (8.33% Upside)
$277.58 (8.33% Upside)
Blogger Sentiment
Neutral
GB:0HR2 Sentiment 53%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.30%
12-Months-Change
Fundamentals
Return on Equity
4.01%
Trailing 12-Months
Asset Growth
8.21%
Trailing 12-Months
Company Description
CME Group
CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the verification, settlement, and guarantee of futures, options, and cleared swap agreements traded across its venues. It also offers services for transaction processing and risk mitigation. Furthermore, the organization provides diverse market data services, encompassing both real-time and historical data feeds. Its wide-ranging client base consists of professional traders, financial institutions, both institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. Founded in Chicago, Illinois, in 1898, the enterprise was formerly known as Chicago Mercantile Exchange Holdings Inc. before rebranding as CME Group Inc. in July 2007.
0HR2 Company Deck
0HR2 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial performance: record Q2 revenue for the quarter, robust ADV and open interest growth, healthy margins, sizeable shareholder returns, and a clear pipeline of product innovation (24/7 trading, Single Stock futures, Compute Futures, Treasury Link). The principal negatives were regulatory uncertainty (CFTC stay and pending litigation), strategic caution and market-risk concerns around perpetual futures, and early-stage monetization for prediction markets. On balance, the positive execution, growth trends and product roadmap materially outweigh the regulatory and product-structure headwinds.View all GB:0HR2 earnings summaries0HR2 Revenue Breakdown
80.99% Clearing and transaction fees
12.32% Market data and information services
6.69% Other

0HR2 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$277.58
▲(8.33% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Cboe Global Markets
―
Intercontinental Exchange
―
S&P Global
―
Nasdaq
―
Coinbase Global
―












